Lv5
986 积分 2023-02-24 加入
Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu–NYM032 for theranostic use in prostate cancer
6小时前
已完结
Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile
7小时前
已完结
Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy
7小时前
已完结
Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies
7小时前
已完结
Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors
7小时前
已完结
Abstract ND07: FXX489, a FAP targeting ligand with best-in-class potential for radioligand therapy
13天前
已关闭
Efficacy and safety of interventions for metastatic castration resistant prostate cancer (mCRPC) patients progressing on androgen receptor-axis-targeted (ARAT) therapy: a systematic literature review
19天前
已完结
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
20天前
已完结
[177Lu]Lu-XYIMSR-01: A Novel CAIX-Targeted Radiotherapeutic for Enhanced Treatment of Malignant Glioma
27天前
已完结
A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC
27天前
已完结
皖公网安备34019202002308
